INTELLECTUAL PROPERTY AND TECHNOLOGY TRANSACTIONS

Our Intellectual Property (“IP”) and technology transactions practice focuses on IP-intensive transactions where IP assets are critical to the structure, the deal and the business goals, e.g., in IP licensing for complex technological and pharmaceutical assets, IP acquisition or divestitures, sponsored research arrangement, strategic collaboration or co-development partnership, and strategic alliances or joint ventures.

Another major part of our IP and technology transaction practice involves assisting our corporate team in handling corporate transactions by conducting IP due diligence and advising on IP issues. Our IP team also has extensive experience in assisting investment funds and other investors with IP due diligence for their investments in the United States and Europe.

Our IP professionals are experienced in a broad range of industries and technology fields including: life sciences, biotechnology, pharmaceuticals, chemical engineering, new chemical compounds, antibodies, molecular diagnostics, gene therapies, cell therapies, cell reprogramming, liquid biopsy, gene editing, vaccines, immunotherapies, medical device, telecommunication, consumer electronics, semiconductor, computer software and hardware, wireless and mobile, Internet, robot, and artificial intelligence.

Our IP attorneys have advanced degrees in their respective fields and have decades of combined experiences. Their deep technical knowledge and experience allow them to quickly understand your technology and apply their legal skills to your matters precisely and efficiently.